BOT 2.63% 37.0¢ botanix pharmaceuticals ltd

I don't disagree on that point and can understand.. frustrating...

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 3,531 Posts.
    lightbulb Created with Sketch. 890
    I don't disagree on that point and can understand.. frustrating still

    as for Q1 of 2022 we can also expect an update on 1801 with phase 2 to kick off, so that will be an ann in itself when they get that underway.

    Phase 3 planning for 1503 "underway" - what ever that means - No real time line commited to within the document.

    as for the canine study, we should actually see results pretty quickly as the testing is to occur on a total of 45 dogs, with 28 day treatment course in total with 2 applications a day.. so should that kick off in 1st half of 22 we should have results pretty quickly and before mid year one would hope.

    as you said - one for the back pocket and to be forgotten about in the interim
 
watchlist Created with Sketch. Add BOT (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.